593 related articles for article (PubMed ID: 24890387)
1. PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1/DM20 alternative splicing.
Taube JR; Sperle K; Banser L; Seeman P; Cavan BC; Garbern JY; Hobson GM
Hum Mol Genet; 2014 Oct; 23(20):5464-78. PubMed ID: 24890387
[TBL] [Abstract][Full Text] [Related]
2. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
[TBL] [Abstract][Full Text] [Related]
3. Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability.
Wang E; Dimova N; Sperle K; Huang Z; Lock L; McCulloch MC; Edgar JM; Hobson GM; Cambi F
Exp Neurol; 2008 Dec; 214(2):322-30. PubMed ID: 18835559
[TBL] [Abstract][Full Text] [Related]
4. PLP1 gene duplication causes overexpression and alteration of the PLP/DM20 splicing balance in fibroblasts from Pelizaeus-Merzbacher disease patients.
Regis S; Grossi S; Corsolini F; Biancheri R; Filocamo M
Biochim Biophys Acta; 2009 Jun; 1792(6):548-54. PubMed ID: 19376225
[TBL] [Abstract][Full Text] [Related]
5. Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes.
Hobson GM; Huang Z; Sperle K; Sistermans E; Rogan PK; Garbern JY; Kolodny E; Naidu S; Cambi F
Hum Mutat; 2006 Jan; 27(1):69-77. PubMed ID: 16287154
[TBL] [Abstract][Full Text] [Related]
6. Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy.
Shy ME; Hobson G; Jain M; Boespflug-Tanguy O; Garbern J; Sperle K; Li W; Gow A; Rodriguez D; Bertini E; Mancias P; Krajewski K; Lewis R; Kamholz J
Ann Neurol; 2003 Mar; 53(3):354-65. PubMed ID: 12601703
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
[TBL] [Abstract][Full Text] [Related]
8. Altered PLP1 splicing causes hypomyelination of early myelinating structures.
Kevelam SH; Taube JR; van Spaendonk RM; Bertini E; Sperle K; Tarnopolsky M; Tonduti D; Valente EM; Travaglini L; Sistermans EA; Bernard G; Catsman-Berrevoets CE; van Karnebeek CD; Østergaard JR; Friederich RL; Fawzi Elsaid M; Schieving JH; Tarailo-Graovac M; Orcesi S; Steenweg ME; van Berkel CG; Waisfisz Q; Abbink TE; van der Knaap MS; Hobson GM; Wolf NI
Ann Clin Transl Neurol; 2015 Jun; 2(6):648-61. PubMed ID: 26125040
[TBL] [Abstract][Full Text] [Related]
9. A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease.
Dhaunchak AS; Nave KA
Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17813-8. PubMed ID: 17962415
[TBL] [Abstract][Full Text] [Related]
10. Proteolipid protein 1 gene mutation in nine patients with Pelizaeus-Merzbacher disease.
Wang JM; Wu Y; Wang HF; Deng YH; Yang YL; Qin J; Li XY; Wu XR; Jiang YW
Chin Med J (Engl); 2008 Sep; 121(17):1638-42. PubMed ID: 19024090
[TBL] [Abstract][Full Text] [Related]
11. Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate.
Appikatla S; Bessert D; Lee I; Hüttemann M; Mullins C; Somayajulu-Nitu M; Yao F; Skoff RP
Glia; 2014 Mar; 62(3):356-73. PubMed ID: 24382809
[TBL] [Abstract][Full Text] [Related]
12. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
[TBL] [Abstract][Full Text] [Related]
13. Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease.
Laššuthová P; Žaliová M; Inoue K; Haberlová J; Sixtová K; Sakmaryová I; Paděrová K; Mazanec R; Zámečník J; Šišková D; Garbern J; Seeman P
J Child Neurol; 2014 Jul; 29(7):924-31. PubMed ID: 23771846
[TBL] [Abstract][Full Text] [Related]
14. A splicing mutation of proteolipid protein 1 in Pelizaeus-Merzbacher disease.
Omata T; Nagai J; Shimbo H; Koizume S; Miyagi Y; Kurosawa K; Yamashita S; Osaka H; Inoue K
Brain Dev; 2016 Jun; 38(6):581-4. PubMed ID: 26725305
[TBL] [Abstract][Full Text] [Related]
15. Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease.
Hobson GM; Davis AP; Stowell NC; Kolodny EH; Sistermans EA; de Coo IF; Funanage VL; Marks HG
Neurology; 2000 Oct; 55(8):1089-96. PubMed ID: 11071483
[TBL] [Abstract][Full Text] [Related]
16. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
[TBL] [Abstract][Full Text] [Related]
17. Morpholino Antisense Oligomers as a Potential Therapeutic Option for the Correction of Alternative Splicing in PMD, SPG2, and HEMS.
Tantzer S; Sperle K; Kenaley K; Taube J; Hobson GM
Mol Ther Nucleic Acids; 2018 Sep; 12():420-432. PubMed ID: 30195779
[TBL] [Abstract][Full Text] [Related]
18. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional study of novel PLP1 mutations in Chinese patients with Pelizaeus-Merzbacher disease.
Xie H; Feng H; Ji J; Wu Y; Kou L; Li D; Ji H; Wu X; Niu Z; Wang J; Jiang Y
Brain Dev; 2015 Sep; 37(8):797-802. PubMed ID: 25491635
[TBL] [Abstract][Full Text] [Related]
20. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]